Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial cells are specialized squamous epithelial cells that form a single-cell-thick layer lining the interior surface of all blood vessels and lymphatic vessels. They serve as a critical interface between circulating blood/lymph and surrounding tissues, regulating vascular tone, hemostasis, angiogenesis, and immune responses. Dysfunction or damage to endothelial cells is implicated in various diseases, making them an important therapeutic target.
Varies depending on the drug. Examples include: Nitric oxide donors promote vasodilation; VEGF inhibitors block angiogenesis; ACE inhibitors affect blood pressure; Monoclonal antibodies block cell adhesion molecules, preventing endothelial cell activation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial Cells (ECs).